about
Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patientsPsychological resilience and neurocognitive performance in a traumatized community sample.Resilience characteristics mitigate tendency for harmful alcohol and illicit drug use in adults with a history of childhood abuse: a cross-sectional study of 2024 inner-city men and women.Coping styles: longitudinal development from ages 17 to 33 and associations with psychiatric disorders.Blood gene expression profiles suggest altered immune function associated with symptoms of generalized anxiety disorderDICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression.Factors associated with functional recovery in bipolar disorder patients.Family environment and adult resilience: contributions of positive parenting and the oxytocin receptor geneCognition and disability in bipolar disorder: lessons from schizophrenia research.Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder.Psychological resilience is associated with more intact social functioning in veterans with post-traumatic stress disorder and depression.Resilience and Biomarkers of Health Risk in Black Smokers and Nonsmokers.Expression of the PPM1F Gene Is Regulated by Stress and Associated With Anxiety and Depression.Gene expression in cord blood links genetic risk for neurodevelopmental disorders with maternal psychological distress and adverse childhood outcomesAffect, inflammation, and health in urban at-risk civiliansBrain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementiaShared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain
P50
Q28301204-61B45426-6243-40BD-9145-99659012E24BQ34054046-117F1C68-E482-4596-8819-650477E36871Q34401456-78F20759-67B5-4B4B-9A88-5555108D27E8Q35040003-4533392B-C846-44F6-8224-28FA98F00465Q35226572-71CD270F-4C9D-4EB6-8714-49A406D78224Q36392527-FDE3CFCB-C03D-4FD1-A775-56DCB63A2439Q37109808-B967A35B-8924-4B25-9003-A1A97C59EBC5Q37185548-A6EE2201-B51A-4088-81CC-7800A130A9BEQ37773405-8E6E1616-3A9D-47EB-9CEC-B6E4D638213FQ39291412-F629A5F8-1A7F-4B26-8B59-631EC0710904Q39302694-61C66A27-83F4-4BF1-9A96-2304885FA044Q39311536-2B6C9E21-D71C-4DDB-91DF-6C3EDBAC7CA8Q46278878-6B2B3975-8D94-425A-B774-EB4851E5CB86Q56909112-68A43E27-1FDB-423D-BA16-0B26F2B3C83DQ57165036-BC3F11C7-9083-43C0-A22D-6F1E0E984320Q89667617-EA9D000E-7EDA-4DC6-990D-ADB34E58F307Q95328349-D810FA8B-805A-4502-9CA4-7A6D66AD5421
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Aliza P Wingo
@ast
Aliza P Wingo
@en
Aliza P Wingo
@es
Aliza P Wingo
@nl
type
label
Aliza P Wingo
@ast
Aliza P Wingo
@en
Aliza P Wingo
@es
Aliza P Wingo
@nl
prefLabel
Aliza P Wingo
@ast
Aliza P Wingo
@en
Aliza P Wingo
@es
Aliza P Wingo
@nl
P106
P31
P496
0000-0002-6360-6726